CN1869704B - Method for quickly determining host protein interaction with pathogenic bacteria - Google Patents
Method for quickly determining host protein interaction with pathogenic bacteria Download PDFInfo
- Publication number
- CN1869704B CN1869704B CN2006100914817A CN200610091481A CN1869704B CN 1869704 B CN1869704 B CN 1869704B CN 2006100914817 A CN2006100914817 A CN 2006100914817A CN 200610091481 A CN200610091481 A CN 200610091481A CN 1869704 B CN1869704 B CN 1869704B
- Authority
- CN
- China
- Prior art keywords
- pathogenic bacteria
- host
- protein
- bacteria
- pathogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 244000052616 bacterial pathogen Species 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title claims abstract description 19
- 230000006916 protein interaction Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 90
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 90
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000012528 membrane Substances 0.000 claims abstract description 7
- 239000003480 eluent Substances 0.000 claims abstract description 6
- 241000894006 Bacteria Species 0.000 claims description 33
- 239000006228 supernatant Substances 0.000 claims description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 27
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 22
- 239000008098 formaldehyde solution Substances 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 14
- 239000004202 carbamide Substances 0.000 claims description 14
- 238000011534 incubation Methods 0.000 claims description 7
- 238000004949 mass spectrometry Methods 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 6
- 230000003993 interaction Effects 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 claims 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 abstract description 18
- 239000003344 environmental pollutant Substances 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 231100000719 pollutant Toxicity 0.000 abstract description 2
- 241000251522 Cephalochordata Species 0.000 description 10
- 210000001124 body fluid Anatomy 0.000 description 10
- 239000010839 body fluid Substances 0.000 description 10
- 241001646716 Escherichia coli K-12 Species 0.000 description 8
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 241000191940 Staphylococcus Species 0.000 description 6
- 230000002779 inactivation Effects 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 239000002504 physiological saline solution Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 102000007863 pattern recognition receptors Human genes 0.000 description 5
- 108010089193 pattern recognition receptors Proteins 0.000 description 5
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 4
- 102000002689 Toll-like receptor Human genes 0.000 description 4
- 108020000411 Toll-like receptor Proteins 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 101710177847 Actin, muscle Proteins 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 102000016918 Complement C3 Human genes 0.000 description 1
- 108010028780 Complement C3 Proteins 0.000 description 1
- 102000007390 Glycogen Phosphorylase Human genes 0.000 description 1
- 108010046163 Glycogen Phosphorylase Proteins 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101000998953 Homo sapiens Immunoglobulin heavy variable 1-2 Proteins 0.000 description 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
- 102100036887 Immunoglobulin heavy variable 1-2 Human genes 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100153375 Mus musculus Tlr4 gene Proteins 0.000 description 1
- 108010060804 Toll-Like Receptor 4 Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 230000033289 adaptive immune response Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 108010089520 pol Gene Products Proteins 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- OXUXQTLJGMPEAY-UHFFFAOYSA-N urea trihydrochloride Chemical compound Cl.Cl.Cl.NC(N)=O OXUXQTLJGMPEAY-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种宿主蛋白,尤其是涉及一种运用革兰氏阳性和阴性灭活病原菌快速分离纯化与之互作的宿主蛋白,特别是其中微量蛋白的方法。The present invention relates to a host protein, in particular to a method for quickly separating and purifying interacting host proteins, especially trace proteins, by using gram-positive and negative inactivated pathogenic bacteria.
背景技术Background technique
多细胞生物如果无法感知并消除微生物的入侵将无法生存,由于微生物分子的异质性和高速度的进化,辨别它们是很困难的。但生物已经进化出几种策略来完成该任务,模式识别策略(pattern-recognition strategy)就是其中一个,生物通过模式识别受体(PRRs)与病原的模式相关的分子模式(PAMPs)结合识别病原,启动信息传递机制。Toll-like receptor(TLR)家族是最具代表性的PRRs,1996年Hoffmann的研究小组在果蝇中发现了作为模式识别受体的Toll受体。1年后,又从人体内找到了可激发获得性免疫的Toll同源物(即Toll-like receptor4,TLR4)。到20世纪90年代,发现鼠的TLR4是识别脂多糖的受体,此后,许多哺乳动物的TLRs受体陆续被发现,它们分别识别特异的PAMPs。TLR的发现使人们意识到先天性的免疫反应不仅是机体抵抗微生物的第一道防线,而且也是激发获得性免疫反应的关键步骤。通过病原菌与动物的宿主体液蛋白互作,然后洗脱黏附在病原菌表面的宿主蛋白,有望获得宿主体液防御体系中参与识别入侵病原菌的某些蛋白,甚至可能找到一些新的PRRs,以进一步阐明宿主启动免疫反应的信息传递机制。新加坡国立大学的Zhu等人(Zhu Y,Thangamani S,Ho B and Ding JL.The ancient origin of the complement system.TheEMBO Journal.2005,24:382-394.)用活葡萄球菌(Staphylococcus aureus)吸附宿主鲎的血清,从中分离出了与病原菌互作的与脊椎动物补体C3功能类似的CrC3,然而其葡萄球菌的阴性对照组中出现了许多来自病原菌的杂带,很难与来自宿主的蛋白区分开,这对后续的研究带来了许多不便,特别是无法鉴定出低丰度的蛋白质。Multicellular organisms cannot survive without the ability to sense and eliminate microbial invasion, and identifying microbial molecules is difficult due to their molecular heterogeneity and high rate of evolution. But organisms have evolved several strategies to accomplish this task, pattern-recognition strategy is one of them, organisms recognize pathogens through the combination of pattern-recognition receptors (PRRs) and pathogenic pattern-associated molecular patterns (PAMPs), Start the messaging mechanism. The Toll-like receptor (TLR) family is the most representative PRRs. In 1996, Hoffmann's research team discovered Toll receptors as pattern recognition receptors in Drosophila. One year later, a Toll homolog (namely Toll-like receptor4, TLR4) that can stimulate acquired immunity was found from the human body. In the 1990s, it was discovered that mouse TLR4 was the receptor for recognizing lipopolysaccharide. Since then, many mammalian TLRs receptors have been discovered one after another, and they respectively recognize specific PAMPs. The discovery of TLRs made people realize that the innate immune response is not only the first line of defense against microorganisms, but also a key step in stimulating the acquired immune response. Through the interaction between pathogenic bacteria and animal host humoral proteins, and then eluting the host proteins adhered to the surface of pathogenic bacteria, it is expected to obtain some proteins involved in the recognition of invading pathogenic bacteria in the host humoral defense system, and may even find some new PRRs to further elucidate the host Messaging mechanism that initiates the immune response. Zhu et al. (Zhu Y, Thangamani S, Ho B and Ding JL. The ancient origin of the complement system. The EMBO Journal. 2005, 24: 382-394.) from the National University of Singapore used live staphylococcus (Staphylococcus aureus) to adsorb the host Limulus serum, from which CrC3, which interacts with pathogenic bacteria and has a similar function to vertebrate complement C3, was isolated. However, many bands from pathogenic bacteria appeared in the negative control group of Staphylococcus, which were difficult to distinguish from proteins from the host. , which brought a lot of inconvenience to subsequent research, especially the inability to identify low-abundance proteins.
发明内容Contents of the invention
本发明的目的在于针对宿主中与病原菌互作的蛋白,存在使用活菌时来自病原菌的蛋白污染样品的不足之处,提供一种快速可靠检测鉴定与病原菌互作的宿主蛋白的方法。The purpose of the present invention is to provide a method for fast and reliable detection and identification of host proteins interacting with pathogenic bacteria for the protein in the host that interacts with pathogenic bacteria.
为此本发明所采用的技术方案是采用灭活的病原菌与宿主蛋白在体外互作,其步骤为:For this reason, the technical solution adopted in the present invention is to use inactivated pathogenic bacteria to interact with host proteins in vitro, and the steps are:
1)利用甲醛灭活病原菌;1) Utilize formaldehyde to inactivate pathogenic bacteria;
2)用洗脱液去除病原菌菌体外膜上易脱落的成分;2) Use the eluent to remove the components that are easy to fall off on the outer membrane of the pathogenic bacteria;
3)让病原菌与宿主蛋白孵育,让宿主蛋白中能与病原菌互作的蛋白黏附到病原菌的表面;3) Incubate the pathogenic bacteria with the host protein, so that the protein in the host protein that can interact with the pathogenic bacteria adheres to the surface of the pathogenic bacteria;
4)用洗脱液收集互作的宿主蛋白。4) Use the eluate to collect the interacting host proteins.
在步骤1)中所述的灭活病原菌是将用生理盐水洗过至少1遍的病原菌用0.5%-1%的甲醛溶液重悬;在70~90℃灭活30~90min。The inactivation of pathogenic bacteria in step 1) is to resuspend the pathogenic bacteria washed at least once with physiological saline with 0.5%-1% formaldehyde solution; inactivate at 70-90° C. for 30-90 minutes.
在步骤2)中所述的去除病原菌外膜上易脱落的成分是以4000~15000g离心至少2min,去除甲醛溶液;然后用含4~5M urea(以4.5M为佳)的pH为7.4~8.5(以8.0为佳)的0.01M Tris-HCl溶液重悬菌体,震荡60~120min(以90min为佳),以4000~15000g离心至少2min,去上清,至少重复1次;最后用生理盐水洗至少1遍,离心至少2min,去除上清。In step 2), the components that are easy to fall off on the outer membrane of pathogenic bacteria are removed by centrifuging at 4000~15000g for at least 2min to remove the formaldehyde solution; Resuspend the cells in 0.01M Tris-HCl solution (preferably 8.0), shake for 60-120min (preferably 90min), centrifuge at 4000-15000g for at least 2min, remove the supernatant, repeat at least once; finally use normal saline Wash at least once, centrifuge for at least 2min, and remove the supernatant.
在步骤3)中所述的病原菌与宿主蛋白孵育是把宿主蛋白和病原菌混匀,震荡30~120min(最好为90min),以4000~15000g离心至少2min,去上清;最后用生理盐水洗至少1遍,4000~15000g离心至少2min,去除上清。In step 3), the incubation of pathogenic bacteria and host protein is to mix the host protein and pathogenic bacteria, shake for 30-120min (preferably 90min), centrifuge at 4000-15000g for at least 2min, remove the supernatant; finally wash with normal saline At least once, centrifuge at 4000-15000g for at least 2min, and remove the supernatant.
在步骤4)中所述的用洗脱液收集互作的宿主蛋白是用4~5M urea的Tris-HCl溶液(以4M urea为佳)重悬菌体,以4000~15000g离心至少2min,所得的菌体待用;上清加入3~5倍体积的丙酮,置于低于-20℃的温度下至少30min,在3~6℃的温度下以10000~30000g离心至少10min,沉淀干燥,用pH为7.4~8.5(以pH8.0为佳)的0.01MTris-HCl溶液或者0.01M PBS溶液重悬,用Bradford检测法测定蛋白浓度,然后进一步用SDS-PAGE分析,最后进行质谱鉴定。In step 4), the collection of interacting host proteins with the eluent is to resuspend the bacteria with 4-5M urea Tris-HCl solution (4M urea is preferred), and centrifuge at 4000-15000g for at least 2min to obtain The bacterial cells were set aside; add 3-5 times the volume of acetone to the supernatant, place it at a temperature lower than -20°C for at least 30 minutes, centrifuge at 10000-30000g at a temperature of 3-6°C for at least 10 minutes, dry the precipitate, and use Resuspend in 0.01M Tris-HCl solution or 0.01M PBS solution with a pH of 7.4-8.5 (preferably pH 8.0), determine the protein concentration by Bradford assay, then further analyze by SDS-PAGE, and finally identify by mass spectrometry.
在步骤4)中,所得的菌体用生理盐水洗至少1遍后,可以与在步骤3)中的宿主蛋白上清重新混匀,然后按上述步骤3)和4)洗脱所需的蛋白。所述的菌体和宿主蛋白上清可以重复利用至少3次。In step 4), the obtained cells are washed at least once with normal saline, and can be re-mixed with the host protein supernatant in step 3), and then the desired protein can be eluted according to the above steps 3) and 4). . The bacterium and host protein supernatant can be reused at least 3 times.
与现有的采用活菌捕捉的方法相比,由于本发明利用灭活病原菌捕捉宿主体内相互作用蛋白,采用灭活的病原菌来吸附宿主蛋白,避免了因为活菌而使互作的宿主蛋白受到病原菌外膜或者分泌蛋白污染的问题。因此本发明的突出优点在于所得到的蛋白全是来源于宿主,无病原菌污染物,是一种高效可靠的检测宿主中参与针对病原菌的防御系统中的首道防线中的蛋白组成情况的方法。Compared with the existing method of capturing live bacteria, the present invention uses inactivated pathogenic bacteria to capture interacting proteins in the host, and uses inactivated pathogenic bacteria to adsorb host proteins, avoiding the interaction of host proteins due to live bacteria. The problem of contamination of the outer membrane or secreted protein of pathogenic bacteria. Therefore, the outstanding advantage of the present invention is that the obtained proteins are all derived from the host, without pathogenic bacteria pollutants, and it is an efficient and reliable method for detecting the composition of proteins in the host participating in the first line of defense in the defense system against pathogenic bacteria.
附图说明Description of drawings
图1为与大肠杆菌K12相互作用的文昌鱼体液蛋白的SDS/PAGE分析。在图1中,1.活病原菌的阴性对照(灭活葡萄球菌与生理盐水孵育);2.与活病原菌互作的宿主蛋白(灭活葡萄球菌与文昌鱼体液蛋白孵育)。Figure 1 is the SDS/PAGE analysis of amphioxus humoral proteins interacting with Escherichia coli K12. In Fig. 1, 1. Negative control of live pathogenic bacteria (inactivated staphylococcus was incubated with normal saline); 2. Host protein interacting with live pathogenic bacteria (inactivated staphylococcus was incubated with amphioxus body fluid protein).
图2为本发明与金黄色葡萄球菌相互作用的文昌鱼体液蛋白的SDS/PAGE分析。在图2中,1.为与病原菌互作的宿主蛋白(灭活K12与文昌鱼体液孵育);2.为病原菌的阴性对照(灭活K12与生理盐水孵育)。Fig. 2 is the SDS/PAGE analysis of amphioxus body fluid proteins interacting with Staphylococcus aureus in the present invention. In Fig. 2, 1. is the host protein that interacts with pathogenic bacteria (inactivated K12 is incubated with amphioxus body fluid); 2. is the negative control of pathogenic bacteria (inactivated K12 is incubated with normal saline).
图3为本发明与嗜水气假单胞菌相互作用的文昌鱼体液蛋白的SDS/PAGE分析。在图3中,1.为与病原菌互作的宿主蛋白(灭活金黄色葡萄球菌与文昌鱼体液孵育);2.为病原菌的阴性对照(灭活金黄色葡萄球菌仅与生理盐水孵育)。Fig. 3 is the SDS/PAGE analysis of the amphioxus humoral protein interacting with Aeropseudomonas hydrophila according to the present invention. In Fig. 3, 1. is the host protein that interacts with pathogenic bacteria (inactivated Staphylococcus aureus is incubated with amphioxus body fluid); 2. is the negative control of pathogenic bacteria (inactivated Staphylococcus aureus is only incubated with normal saline).
图4为本发明与大肠杆菌K12相互作用的果蝇体液蛋白的SDS/PAGE分析。在图4中,1.为与病原菌互作的宿主蛋白(灭活大肠杆菌K12与果蝇体液孵育);2.为病原菌的阴性对照(灭活大肠杆菌K12仅与生理盐水孵育)。Fig. 4 is the SDS/PAGE analysis of Drosophila humoral proteins interacting with Escherichia coli K12 of the present invention. In Figure 4, 1. is the host protein that interacts with pathogenic bacteria (inactivated Escherichia coli K12 was incubated with Drosophila body fluid); 2. is the negative control of pathogenic bacteria (inactivated Escherichia coli K12 was only incubated with normal saline).
图5为本发明与金黄色葡萄球菌相互作用的小白鼠体液蛋白的SDS/PAGE分析。在图5中,1.为与病原菌互作的宿主蛋白(灭活金黄色葡萄球菌与小白鼠血清孵育);2.为病原菌的阴性对照(灭活金黄色葡萄球菌仅与生理盐水孵育)。Fig. 5 is the SDS/PAGE analysis of the body fluid protein of mice interacting with Staphylococcus aureus of the present invention. In Figure 5, 1. is the host protein that interacts with pathogenic bacteria (inactivated Staphylococcus aureus was incubated with mouse serum); 2. is the negative control of pathogenic bacteria (inactivated Staphylococcus aureus was only incubated with normal saline).
具体实施方式Detailed ways
实施例1Example 1
1、病原菌灭活:1. Inactivation of pathogenic bacteria:
实验采用的大肠杆菌K12(Escherichia coli K12)为本实验室保存菌种。挑取该菌株的单菌落,接种于500ml培养基中37℃,200rpm,12h摇菌,5000g室温,离心10min,去上清;菌体用生理盐水洗过3遍,5000g室温,离心10min;所得菌体分别用1%的甲醛溶液重悬;80。℃灭活90min。The Escherichia coli K12 (Escherichia coli K12) used in the experiment is the strain preserved in the laboratory. Pick a single colony of the strain, inoculate it in 500ml culture medium at 37°C, 200rpm, shake the bacteria for 12h, centrifuge at room temperature at 5000g for 10min, remove the supernatant; wash the bacteria three times with normal saline, centrifuge at room temperature at 5000g for 10min; Bacteria were resuspended with 1% formaldehyde solution; 80. ℃ inactivation for 90min.
2、去除病原菌表面易脱落的成分:2. Remove the components that are easy to fall off on the surface of pathogenic bacteria:
12000g,室温5min离心,去除甲醛溶液;然后用含4.5M urea的0.01M Tris-HCl(pH8.0)溶液重悬菌体,轻摇90min,12000g,室温5min离心,去上清,重复3次;最后用8.5%的生理盐水洗3遍(12000g,5min离心,室温去上清)。Centrifuge at 12000g at room temperature for 5min to remove the formaldehyde solution; then resuspend the cells with 0.01M Tris-HCl (pH8.0) solution containing 4.5M urea, shake gently for 90min, centrifuge at 12000g at room temperature for 5min, remove the supernatant, repeat 3 times ;Finally washed 3 times with 8.5% physiological saline (12000g, 5min centrifugation, room temperature to remove the supernatant).
3、病原菌与宿主蛋白孵育:3. Pathogen and host protein incubation:
把病原菌平分成两组,一组与文昌鱼体液混匀,另一组作为对照组与等体积生理盐水混匀;都置于室温,轻摇60min;12000g 4℃离心5min;文昌鱼的血清4℃暂时保存;最后两组都用8.5%的生理盐水洗3遍。Divide the pathogenic bacteria into two groups, one group is mixed with the amphioxus body fluid, and the other group is used as the control group and mixed with an equal volume of normal saline; both are placed at room temperature and shaken gently for 60 minutes; centrifuged at 12000g for 5 minutes at 4°C; Temporarily stored at ℃; the last two groups were washed 3 times with 8.5% normal saline.
4、蛋白洗脱4. Protein elution
用含4M urea的0.01M Tris-HCl(pH 8.0)溶液分别重悬菌体,室温轻摇60min,分别于12000g,4℃,5min离心,菌体分别都收于4℃;上清分别加入4倍体积的丙酮,置于-20℃,过夜,12000g,4℃,离心20min,沉淀风干,用0.01M Tris-HCl(pH 8.0)溶液溶液重悬,然后进一步用SDS-PAGE分析结果见图1,最后进行质谱鉴定发现1号蛋白为histone h4,并且蛋白得分具有显著性。检测结果见图1。Resuspend the bacteria in 0.01M Tris-HCl (pH 8.0) solution containing 4M urea, shake gently at room temperature for 60min, centrifuge at 12000g, 4°C, 5min respectively, and collect the bacteria at 4°C respectively; add 4 Double the volume of acetone, place at -20°C overnight, centrifuge at 12000g, 4°C for 20min, air-dry the precipitate, resuspend with 0.01M Tris-HCl (pH 8.0) solution, and then further analyze the results by SDS-PAGE as shown in Figure 1 , and finally identified by mass spectrometry, it was found that protein No. 1 was histone h4, and the protein score was significant. The test results are shown in Figure 1.
实施例2Example 2
1、病原菌灭活:1. Inactivation of pathogenic bacteria:
实验采用的金黄色葡萄球菌(Staphylococcus aureaus)为本实验室保存菌种。挑取该菌株的单菌落,接种于500ml培养基中37℃,200rpm,12h摇菌,5000g室温,离心10min,去上清;菌体用生理盐水洗过3遍,5000g室温,离心10min;所得菌体分别用1%的甲醛溶液重悬;70℃灭活90min。Staphylococcus aureaus was used in the experiment as a strain preserved in our laboratory. Pick a single colony of the strain, inoculate it in 500ml culture medium at 37°C, 200rpm, shake the bacteria for 12h, centrifuge at room temperature at 5000g for 10min, remove the supernatant; wash the bacteria three times with normal saline, centrifuge at room temperature at 5000g for 10min; Bacteria were resuspended with 1% formaldehyde solution; inactivated at 70°C for 90 minutes.
2、去除病原菌表面易脱落的成分:2. Remove the components that are easy to fall off on the surface of pathogenic bacteria:
12000g,室温5min离心,去除甲醛溶液;然后用含4.5M urea的0.01M Tris-HCl(pH8.0)溶液重悬菌体,轻摇90min,12000g,室温5min离心,去上清,重复3次;最后用8.5%的生理盐水洗3遍(12000g,5min离心,室温去上清)。Centrifuge at 12000g at room temperature for 5min to remove the formaldehyde solution; then resuspend the cells with 0.01M Tris-HCl (pH8.0) solution containing 4.5M urea, shake gently for 90min, centrifuge at 12000g at room temperature for 5min, remove the supernatant, repeat 3 times ;Finally washed 3 times with 8.5% physiological saline (12000g, 5min centrifugation, room temperature to remove the supernatant).
3、病原菌与宿主蛋白孵育:3. Pathogen and host protein incubation:
把病原菌平分成两组,一组与文昌鱼体液混匀,另一组作为对照组与等体积生理盐水混匀;都置于室温,轻摇60min;12000g 4℃离心5min;文昌鱼的血清4℃暂时保存;最后两组都用8.5%的生理盐水洗3遍。Divide the pathogenic bacteria into two groups, one group is mixed with the amphioxus body fluid, and the other group is used as the control group and mixed with an equal volume of normal saline; both are placed at room temperature and shaken gently for 60 minutes; centrifuged at 12000g for 5 minutes at 4°C; Temporarily stored at ℃; the last two groups were washed 3 times with 8.5% normal saline.
4、蛋白洗脱4. Protein elution
用含4M urea的0.01M Tris-HCl(pH 8.0)溶液分别重悬菌体,室温轻摇60min,分别于12000g,4℃,5min离心,菌体分别都收于4℃;上清分别加入4倍体积的丙酮,置于-20℃,过夜,12000g,4℃,离心20min,沉淀风干,用0.01M Tris-HCl(pH 8.0)溶液溶液重悬,然后进一步用SDS-PAGE分析结果见图2,最后进行质谱鉴定发现1号蛋白为pol protein,并且蛋白得分具有显著性。检测结果见图2。Resuspend the bacteria in 0.01M Tris-HCl (pH 8.0) solution containing 4M urea, shake gently at room temperature for 60min, centrifuge at 12000g, 4°C, 5min respectively, and collect the bacteria at 4°C respectively; add 4 Double the volume of acetone, place at -20°C overnight, centrifuge at 12000g, 4°C for 20min, air-dry the precipitate, resuspend with 0.01M Tris-HCl (pH 8.0) solution, and then further analyze the results by SDS-PAGE as shown in Figure 2 , and finally identified by mass spectrometry, it was found that protein No. 1 was pol protein, and the protein score was significant. The test results are shown in Figure 2.
实施例3Example 3
1、病原菌灭活:1. Inactivation of pathogenic bacteria:
实验采用的嗜水气单胞菌(Aeromonas hydrophila)为本实验室保存菌种。挑取该菌株的单菌落,接种于500ml培养基中37℃,200rpm,12h摇菌,5000g室温,离心10min,去上清;菌体用生理盐水洗过3遍,5000g室温,离心10min;所得菌体分别用1%的甲醛溶液重悬;80℃灭活90min。The Aeromonas hydrophila used in the experiment is the strain preserved in our laboratory. Pick a single colony of the strain, inoculate it in 500ml culture medium at 37°C, 200rpm, shake the bacteria for 12h, centrifuge at room temperature at 5000g for 10min, remove the supernatant; wash the bacteria three times with normal saline, centrifuge at room temperature at 5000g for 10min; The bacteria were resuspended with 1% formaldehyde solution; inactivated at 80°C for 90min.
2、去除病原菌表面易脱落的成分:2. Remove the components that are easy to fall off on the surface of pathogenic bacteria:
12000g,室温5min离心,去除甲醛溶液;然后用含4.5M urea的0.01M Tris-HCl(pH8.0)溶液重悬菌体,轻摇90min,12000g,室温5min离心,去上清,重复3次;最后用8.5%的生理盐水洗3遍(12000g,5min离心,室温去上清)。Centrifuge at 12000g at room temperature for 5min to remove the formaldehyde solution; then resuspend the cells with 0.01M Tris-HCl (pH8.0) solution containing 4.5M urea, shake gently for 90min, centrifuge at 12000g at room temperature for 5min, remove the supernatant, repeat 3 times ;Finally washed 3 times with 8.5% physiological saline (12000g, 5min centrifugation, room temperature to remove the supernatant).
3、病原菌与宿主蛋白孵育:3. Pathogen and host protein incubation:
把病原菌平分成两组,一组与文昌鱼体液混匀,另一组作为对照组与等体积生理盐水混匀;都置于室温,轻摇60min;12000g 4℃离心5min;文昌鱼的血清4℃暂时保存;最后两组都用8.5%的生理盐水洗3遍。Divide the pathogenic bacteria into two groups, one group is mixed with the amphioxus body fluid, and the other group is used as the control group and mixed with an equal volume of normal saline; both are placed at room temperature and shaken gently for 60 minutes; centrifuged at 12000g for 5 minutes at 4°C; Temporarily stored at ℃; the last two groups were washed 3 times with 8.5% normal saline.
4、蛋白洗脱4. Protein elution
用含4M urea的0.01M Tris-HCl(pH 8.0)溶液分别重悬菌体,室温轻摇60min,分别于12000g,4℃,5min离心,菌体分别都收于4℃;上清分别加入4倍体积的丙酮,置于-20℃,过夜,12000g,4℃,离心20min,沉淀风干,用0.01M Tris-HCl(pH 8.0)溶液溶液重悬,然后进一步用SDS-PAGE分析结果见图3,最后进行质谱鉴定发现1号蛋白为Actin,muscle,并且蛋白得分具有显著性。检测结果见图3。Resuspend the bacteria in 0.01M Tris-HCl (pH 8.0) solution containing 4M urea, shake gently at room temperature for 60min, centrifuge at 12000g, 4°C, 5min respectively, and collect the bacteria at 4°C respectively; add 4 Double the volume of acetone, place at -20°C overnight, centrifuge at 12000g, 4°C for 20min, air-dry the precipitate, resuspend with 0.01M Tris-HCl (pH 8.0) solution, and then further analyze the results by SDS-PAGE as shown in Figure 3 , and finally identified by mass spectrometry, it was found that protein No. 1 was Actin, muscle, and the protein score was significant. The test results are shown in Figure 3.
实施例4Example 4
1、实验采用的大肠杆菌K12(Escherichia coli K12)为本实验室保存菌种。挑取该菌株的单菌落,接种于500ml培养基中37℃,200rpm,12h摇菌,5000g室温,离心10min,去上清;菌体用生理盐水洗过3遍,5000g室温,离心10min;所得菌体分别用1%的甲醛溶液重悬;80℃灭活90min。1. The Escherichia coli K12 (Escherichia coli K12) used in the experiment is the strain preserved in this laboratory. Pick a single colony of the strain, inoculate it in 500ml culture medium at 37°C, 200rpm, shake the bacteria for 12h, centrifuge at room temperature at 5000g for 10min, remove the supernatant; wash the bacteria three times with normal saline, centrifuge at room temperature at 5000g for 10min; The bacteria were resuspended with 1% formaldehyde solution; inactivated at 80°C for 90min.
2、去除病原菌表面易脱落的成分:2. Remove the components that are easy to fall off on the surface of pathogenic bacteria:
12000g,室温5min离心,去除甲醛溶液;然后用含4.5M urea的0.01M Tris-HCl(pH8.0)溶液重悬菌体,轻摇90min,12000g,室温5min离心,去上清,重复3次;最后用8.5%的生理盐水洗3遍(12000g,5min离心,室温去上清)。Centrifuge at 12000g at room temperature for 5min to remove the formaldehyde solution; then resuspend the cells with 0.01M Tris-HCl (pH8.0) solution containing 4.5M urea, shake gently for 90min, centrifuge at 12000g at room temperature for 5min, remove the supernatant, repeat 3 times ;Finally washed 3 times with 8.5% physiological saline (12000g, 5min centrifugation, room temperature to remove the supernatant).
3、病原菌与宿主蛋白孵育:3. Pathogen and host protein incubation:
把病原菌平分成两组,一组与果蝇体液混匀,另一组作为对照组与等体积生理盐水混匀;都置于室温,轻摇60min;12000g 4℃离心5min;文昌鱼的血清4℃暂时保存;最后两组都用8.5%的生理盐水洗3遍。Divide the pathogenic bacteria into two groups, one group is mixed with Drosophila body fluid, and the other group is used as a control group and mixed with an equal volume of normal saline; both are placed at room temperature and gently shaken for 60 minutes; centrifuged at 12000g 4°C for 5 minutes; amphioxus serum 4 Temporarily stored at ℃; the last two groups were washed 3 times with 8.5% normal saline.
4、蛋白洗脱4. Protein elution
用含4M urea的0.01M Tris-HCl(pH 8.0)溶液分别重悬菌体,室温轻摇60min,分别于12000g,4℃,5min离心,菌体分别都收于4℃;上清分别加入4倍体积的丙酮,置于-20℃,过夜,12000g,4℃,离心20min,沉淀风干,用0.01M Tris-HCl(pH 8.0)溶液溶液重悬,然后进一步用SDS-PAGE分析结果见图4,最后进行质谱鉴定发现1号蛋白为glycogen phosphorylase;2号蛋白为ATP synthase beta subunit;并且蛋白得分都具有显著性。检测结果见图4。Resuspend the bacteria in 0.01M Tris-HCl (pH 8.0) solution containing 4M urea, shake gently at room temperature for 60min, centrifuge at 12000g, 4°C, 5min respectively, and collect the bacteria at 4°C respectively; add 4 Double the volume of acetone, place at -20°C overnight, centrifuge at 12000g, 4°C for 20min, air-dry the precipitate, resuspend with 0.01M Tris-HCl (pH 8.0) solution, and then further analyze the results by SDS-PAGE, see Figure 4 , and finally identified by mass spectrometry, it was found that protein No. 1 was glycogen phosphorylase; protein No. 2 was ATP synthase beta subunit; and the protein scores were all significant. The test results are shown in Figure 4.
实施例5Example 5
1、病原菌灭活:1. Inactivation of pathogenic bacteria:
实验采用的金黄色葡萄球菌(Staphylococcus aureaus)为本实验室保存菌种。挑取该菌株的单菌落,接种于500ml培养基中37℃,200rpm,12h摇菌,5000g室温,离心10min,去上清;菌体用生理盐水洗过3遍,5000g室温,离心10min;所得菌体分别用1%的甲醛溶液重悬;70℃灭活90min。Staphylococcus aureaus was used in the experiment as a strain preserved in our laboratory. Pick a single colony of the strain, inoculate it in 500ml culture medium at 37°C, 200rpm, shake the bacteria for 12h, centrifuge at room temperature at 5000g for 10min, remove the supernatant; wash the bacteria three times with normal saline, centrifuge at room temperature at 5000g for 10min; Bacteria were resuspended with 1% formaldehyde solution; inactivated at 70°C for 90 minutes.
2、去除病原菌表面易脱落的成分:2. Remove the components that are easy to fall off on the surface of pathogenic bacteria:
12000g,室温5min离心,去除甲醛溶液;然后用含4.5M urea的0.01M Tris-HCl(pH8.0)溶液重悬菌体,轻摇90min,12000g,室温5min离心,去上清,重复3次;最后用8.5%的生理盐水洗3遍(12000g,5min离心,室温去上清)。Centrifuge at 12000g at room temperature for 5min to remove the formaldehyde solution; then resuspend the cells with 0.01M Tris-HCl (pH8.0) solution containing 4.5M urea, shake gently for 90min, centrifuge at 12000g at room temperature for 5min, remove the supernatant, repeat 3 times ;Finally washed 3 times with 8.5% physiological saline (12000g, 5min centrifugation, room temperature to remove the supernatant).
3、病原菌与宿主蛋白孵育:3. Pathogen and host protein incubation:
把病原菌平分成两组,一组与小白鼠血清混匀,另一组作为对照组与等体积生理盐水混匀;都置于室温,轻摇60min;12000g 4℃离心5min;小白鼠的血清4℃暂时保存;最后两组都用8.5%的生理盐水洗3遍。Divide the pathogenic bacteria into two groups, one group is mixed with the mouse serum, and the other group is used as the control group and mixed with an equal volume of normal saline; both are placed at room temperature and gently shaken for 60 minutes; centrifuged at 12000g for 5 minutes at 4°C; the serum of the mice is 4 Temporarily stored at ℃; the last two groups were washed 3 times with 8.5% normal saline.
4、蛋白洗脱4. Protein elution
用含4M urea的0.01M Tris-HCl(pH 8.0)溶液分别重悬菌体,轻摇60min,分别于12000g,4℃,5min离心,菌体分别都收于4℃;上清分别加入4倍体积的丙酮,置于-20℃过夜;12000g,4℃,离心20min,沉淀风干,用0.01M Tris-HCl(pH 8.0)溶液溶液重悬,然后用SDS-PAGE分析结果见图5,最后进行质谱鉴定发现1号蛋白为immunoglobulinheavy chain variable region,并且蛋白得分具有显著性。检测结果见图5。Resuspend the bacteria in 0.01M Tris-HCl (pH 8.0) solution containing 4M urea, shake gently for 60min, and centrifuge at 12000g, 4°C, 5min respectively, and the bacteria are collected at 4°C respectively; the supernatants are added 4 times volume of acetone, placed at -20°C overnight; 12000g, 4°C, centrifuged for 20min, the precipitate was air-dried, resuspended with 0.01M Tris-HCl (pH 8.0) solution, and then analyzed by SDS-PAGE. The results are shown in Figure 5, and finally carried out Mass spectrometry identified protein No. 1 as immunoglobulin heavy chain variable region, and the protein score was significant. The test results are shown in Figure 5.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006100914817A CN1869704B (en) | 2006-06-14 | 2006-06-14 | Method for quickly determining host protein interaction with pathogenic bacteria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006100914817A CN1869704B (en) | 2006-06-14 | 2006-06-14 | Method for quickly determining host protein interaction with pathogenic bacteria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1869704A CN1869704A (en) | 2006-11-29 |
| CN1869704B true CN1869704B (en) | 2010-06-30 |
Family
ID=37443422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2006100914817A Expired - Fee Related CN1869704B (en) | 2006-06-14 | 2006-06-14 | Method for quickly determining host protein interaction with pathogenic bacteria |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1869704B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1281371A (en) * | 1997-11-17 | 2001-01-24 | 茜泊坎普公司 | Method for obtaining vaccines for preventing pathogenic effects related to retroviral infection |
| WO2004042003A2 (en) * | 2002-11-01 | 2004-05-21 | Promega Corporation | Cell lysis compositions, methods of use, apparatus, and kit |
| CN1590538A (en) * | 2003-09-02 | 2005-03-09 | 中国人民解放军第四军医大学口腔医学院 | Separation and culturing method of human epidermis stem cell |
| CN1668642A (en) * | 2002-08-06 | 2005-09-14 | 安万特医药德国有限公司 | Method for Isolating Intestinal Cholesterol-Binding Protein |
-
2006
- 2006-06-14 CN CN2006100914817A patent/CN1869704B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1281371A (en) * | 1997-11-17 | 2001-01-24 | 茜泊坎普公司 | Method for obtaining vaccines for preventing pathogenic effects related to retroviral infection |
| CN1668642A (en) * | 2002-08-06 | 2005-09-14 | 安万特医药德国有限公司 | Method for Isolating Intestinal Cholesterol-Binding Protein |
| WO2004042003A2 (en) * | 2002-11-01 | 2004-05-21 | Promega Corporation | Cell lysis compositions, methods of use, apparatus, and kit |
| CN1590538A (en) * | 2003-09-02 | 2005-03-09 | 中国人民解放军第四军医大学口腔医学院 | Separation and culturing method of human epidermis stem cell |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1869704A (en) | 2006-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wurpel et al. | Comparative analysis of the uropathogenic Escherichia coli surface proteome by tandem mass-spectrometry of artificially induced outer membrane vesicles | |
| Chapelle et al. | A straightforward and reliable method for bacterial in planta transcriptomics: application to the Dickeya dadantii/Arabidopsis thaliana pathosystem | |
| CN107429290A (en) | Use the method for the pathogenic bacteria of the nano vesicle identification bacterial infection disease from bacterium | |
| Kong et al. | Antimicrobial genes from Allium sativum and Pinellia ternata revealed by a Bacillus subtilis expression system | |
| Zhang et al. | The safety and potential probiotic properties analysis of Streptococcus alactolyticus strain FGM isolated from the chicken cecum | |
| Xiao-Xiao et al. | Polymyxin B as an inhibitor of lipopolysaccharides contamination of herb crude polysaccharides in mononuclear cells | |
| CN117986327B (en) | Antibacterial peptide RS12 and application thereof | |
| Kumar et al. | In-silico antibacterial activity of active phytocompounds from the ethanolic leaves extract of Eichhornia crassipes (Mart) Solms. against selected target pathogen Pseudomonas fluorescens | |
| CN1869704B (en) | Method for quickly determining host protein interaction with pathogenic bacteria | |
| CN107760655A (en) | Aflatoxin degradation enzyme and its application by bacillus subtilis secretion | |
| Brudnak | Application of genomeceuticals to the molecular and immunological aspects of autism | |
| Piovesana et al. | Development of an analytical method for the metaproteomic investigation of bioaerosol from work environments | |
| CN119060987B (en) | Application of bacteriophage depolymerase dep253 in degradation of bacterial capsular polysaccharide | |
| Moguel-Salazar et al. | Antimicrobial activity of aqueous extracts of sea cucumber (Isostichopus badionotus) from the coast of Yucatan, Mexico | |
| CN113528600A (en) | Method for preparing antibacterial peptide by inducing fly maggots with salmonella | |
| CN115369100A (en) | Phage Depo58 based on Klebsiella pneumoniae phage strain P719 and application thereof | |
| Sahoo et al. | Characterization of a lipopolysaccharide-and beta-1, 3-glucan binding protein (LGBP) from the hepatopancreas of freshwater prawn, Macrobrachium rosenbergii, possessing lectin-like activity | |
| CN115038799A (en) | Methods of treating bacterial infections | |
| Mizaeva et al. | Antibacterial Activity of Rainbow Trout Plasma: In Vitro Assays and Proteomic Analysis | |
| CN103451188A (en) | Preparation method of DWD (Double Whey Acidic Protein Domain) antibacterial peptide molecules of fenneropenaeus chinensis | |
| Azemin et al. | Bacteriocin isolated from Halomonas sp.: a bacterial DING protein | |
| Meyer et al. | Bioaerosols in swine confinement buildings: A metaproteomic view | |
| CN102516382A (en) | Antimicrobial peptide Hainanenin-5 of Amolops hainanensis, gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis, separation and purification method and chemical synthesis method for antimicrobial peptide Hainanenin-5 of Amolops hainanensis and application of gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis | |
| CN103243089B (en) | Method for extracting deoxyribonucleic acid (DNA) from tanned animal specimen hide | |
| US20210198308A1 (en) | Honey proteomics for honeybee disease and environmental biomonitoring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100630 Termination date: 20130614 |